Illinois General Assembly - Bill Status for HB1780
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

 Bill Status of HB1780  102nd General Assembly

Short Description:  DRUG TAKE-BACK ACT

House Sponsors
Rep. Jennifer Gong-Gershowitz - Dagmara Avelar, Terra Costa Howard, Anne Stava-Murray, Kelly M. Cassidy, Deb Conroy, Kambium Buckner and Michelle Mussman

Prescription Drug Affordability & Accessibility Committee Hearing Jan 26 2022 3:00PM Virtual Room 5 Springfield, IL

Last Action
DateChamber Action
  1/11/2022HouseAssigned to Prescription Drug Affordability & Accessibility Committee

Statutes Amended In Order of Appearance
New Act
5 ILCS 140/7from Ch. 116, par. 207

Synopsis As Introduced
Provides that the Act may be cited as the Drug Take-Back Act. Requires covered manufacturers to, no later than July 1, 2022 or 6 months after becoming a covered manufacturer, whichever is later, participate in an approved drug take-back program or have established and implemented a drug take-back program independently or as part of a group of covered manufacturers. Provides requirements for the drug take-back program and for manufacturer program operators. Requires each manufacturer program operator to submit a proposal for the establishment and implementation of a drug take-back program to the Environmental Protection Agency for review and approval. Contains provisions regarding changes or modifications to drug take-back programs, promotion of drug take-back programs, annual reports, funding, and reimbursement. Requires covered manufacturers and manufacturer program operators to submit an annual $5,000 registration fee. Provides civil penalties. Contains other provisions. Amends the Freedom of Information Act. Provides that proprietary information submitted to the Environmental Protection Agency under the Pharmaceutical Recovery Act is exempt from inspection and copying under the Act. Preempts home rule. Contains other provisions. Effective immediately.

DateChamber Action
  2/16/2021HouseFiled with the Clerk by Rep. Jennifer Gong-Gershowitz
  2/17/2021HouseFirst Reading
  2/17/2021HouseReferred to Rules Committee
  2/24/2021HouseAdded Co-Sponsor Rep. Terra Costa Howard
  2/26/2021HouseAdded Co-Sponsor Rep. Anne Stava-Murray
  3/1/2021HouseAdded Co-Sponsor Rep. Kelly M. Cassidy
  3/9/2021HouseAdded Co-Sponsor Rep. Deb Conroy
  3/9/2021HouseAssigned to Prescription Drug Affordability & Accessibility Committee
  3/11/2021HouseAdded Co-Sponsor Rep. Kambium Buckner
  3/26/2021HouseAdded Chief Co-Sponsor Rep. Dagmara Avelar
  3/26/2021HouseAdded Co-Sponsor Rep. Michelle Mussman
  3/27/2021HouseRule 19(a) / Re-referred to Rules Committee
  1/11/2022HouseAssigned to Prescription Drug Affordability & Accessibility Committee

Back To Top